title: β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease.
abstract: Alzheimer's disease (AD) and vascular dementia are responsible for up to 90% of dementia cases. According to the World Health Organization (WHO), a staggering number of 35.6 million people are currently diagnosed with dementia. Blocking disease progression or preventing AD altogether is desirable for both social and economic reasons and recently focus has shifted to a new and promising drug: the β-secretase inhibitor. Much of AD research has investigated the amyloid cascade hypothesis, which postulates that AD is caused by changes in amyloid beta (Aβ) stability and aggregation. Blocking Aβ production by inhibiting the first protease required for its generation, β-secretase/BACE1, may be the next step in blocking AD progression. In April 2012, promising phase I data on inhibitor MK-8931 was presented. This drug reduced Aβ cerebral spinal fluids (CSF) levels up to 92% and was well tolerated by patients. In March 2013 data was added from a one week trial in 32 mild to moderate AD patients, showing CSF Aβ levels decreased up to 84%. However, β-site APP cleaving enzyme 1 (BACE1) inhibitors require further research. First, greatly reducing Aβ levels through BACE1 inhibition may have harmful side effects. Second, BACE1 inhibitors have yet to pass clinical trial phase II/III and no data on possible side effects on AD patients are available. And third, there remains doubt about the clinical efficacy of BACE1 inhibitors. In moderate AD patients, Aβ plaques have already been formed. BACE1 inhibitors prevent production of new Aβ plaques, but hypothetically do not influence already existing Aβ peptides. Therefore, BACE1 inhibitors are potentially better at preventing AD instead of having therapeutic use.
authors.affiliation: Department of Geriatric Medicine and Radboud Alzheimer Center, Radboud University Medical Center Nijmegen, Gelderland, Netherlands.
authors.forename: Kelly Willemijn
authors.initials: KW
authors.lastname: Menting
authors.affiliation: Department of Geriatric Medicine and Radboud Alzheimer Center, Radboud University Medical Center Nijmegen, Gelderland, Netherlands.
authors.forename: Jurgen A H R
authors.initials: JA
authors.lastname: Claassen
keywords: APP; Alzheimer’s disease; BACE1; amyloid cascade hypothesis; amyloid-β; drug; β-secretase; β-secretase inhibitors
references.citation: Nature. 1999 Dec 2;402(6761):537-40
references.pmid: 10591214
references.citation: Mol Cell Neurosci. 1999 Dec;14(6):419-27
references.pmid: 10656250
references.citation: Mol Neurodegener. 2007 Nov 15;2:22
references.pmid: 18005427
references.citation: Prog Neurobiol. 2006 Jun;79(2):95-111
references.pmid: 16904810
references.citation: Neuron. 1991 Apr;6(4):487-98
references.pmid: 1673054
references.citation: Nat Neurosci. 2001 Mar;4(3):233-4
references.pmid: 11224536
references.citation: Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9649-53
references.pmid: 8415756
references.citation: Int J Clin Exp Pathol. 2010 Jul 08;3(6):618-28
references.pmid: 20661410
references.citation: Alzheimers Res Ther. 2011 May 31;3(3):20
references.pmid: 21639952
references.citation: Nat Neurosci. 2006 Dec;9(12):1520-5
references.pmid: 17099708
references.citation: EMBO J. 2013 Jul 17;32(14):2015-28
references.pmid: 23792428
references.citation: Ann Neurol. 2002 Jun;51(6):783-6
references.pmid: 12112088
references.citation: Hum Mol Genet. 2001 Jun 1;10(12):1317-24
references.pmid: 11406613
references.citation: Neurobiol Dis. 1996 Feb;3(1):16-32
references.pmid: 9173910
references.citation: J Am Chem Soc. 2000 Apr 12;122(14):3522-3523
references.pmid: 30443047
references.citation: Mol Neurodegener. 2011 Dec 28;6:88
references.pmid: 22204380
references.citation: Curr Alzheimer Res. 2006 Dec;3(5):421-30
references.pmid: 17168641
references.citation: JAMA. 2009 Dec 16;302(23):2557-64
references.pmid: 20009055
references.citation: Nature. 1999 Dec 2;402(6761):533-7
references.pmid: 10591213
references.citation: J Clin Invest. 2003 Aug;112(3):440-9
references.pmid: 12897211
references.citation: Science. 1999 Oct 22;286(5440):735-41
references.pmid: 10531052
references.citation: Nature. 2012 Aug 2;488(7409):96-9
references.pmid: 22801501
references.citation: J Neurosci. 2005 Dec 14;25(50):11693-709
references.pmid: 16354928
references.citation: Nature. 1992 Dec 17;360(6405):672-4
references.pmid: 1465129
references.citation: Trends Pharmacol Sci. 1995 Feb;16(2):67-75
references.pmid: 7762084
references.citation: J Biol Chem. 1996 Feb 23;271(8):4077-81
references.pmid: 8626743
references.citation: Trends Pharmacol Sci. 2004 Feb;25(2):92-7
references.pmid: 15102495
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1456-60
references.pmid: 10677483
references.citation: FASEB J. 2006 Jul;20(9):1369-76
references.pmid: 16816112
references.citation: Nat Neurosci. 2001 Mar;4(3):231-2
references.pmid: 11224535
references.citation: Nat Med. 1997 Jan;3(1):67-72
references.pmid: 8986743
references.citation: Crit Rev Biochem Mol Biol. 2003;38(2):89-119
references.pmid: 12749695
references.citation: Age Ageing. 2006 Jul;35(4):332-5
references.pmid: 16644763
references.citation: J Biol Chem. 2012 Jul 27;287(31):25927-40
references.pmid: 22692213
references.citation: Adv Anat Embryol Cell Biol. 2007;190:1-65
references.pmid: 17432114
references.citation: J Neurochem. 2012 Jan;120 Suppl 1:71-83
references.pmid: 22122681
references.citation: J Neurosci. 2014 Jun 11;34(24):8336-46
references.pmid: 24920637
references.citation: J Biol Chem. 2000 Jul 7;275(27):20647-51
references.pmid: 10749877
references.citation: EMBO J. 2012 Jun 22;31(14):3157-68
references.pmid: 22728825
references.citation: Arch Neurol. 2002 Sep;59(9):1381-9
references.pmid: 12223024
references.citation: J Biol Chem. 2001 Apr 13;276(15):12019-23
references.pmid: 11152683
references.citation: Biochemistry. 2002 Sep 10;41(36):10963-7
references.pmid: 12206667
references.citation: Neuron. 2004 Jan 8;41(1):27-33
references.pmid: 14715132
references.citation: Science. 2006 Oct 27;314(5799):664-6
references.pmid: 16990514
references.citation: Nature. 1999 Apr 8;398(6727):513-7
references.pmid: 10206644